FDA NDC Directory · JSON-LD · Markdown

SINCALIDE

NDC 63323-579 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namesincalide
Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryNew Drug Application (innovator) · App NDA017697
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsSINCALIDE (5 ug/5mL)
Marketing started20230401
Package count1

External sources

Source: openFDA. Public-domain (CC0).